Citadel Advisors’s CareMax, Inc. Class A Common Stock CMAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-173
Closed -$11K 15774
2023
Q3
$11K Buy
+173
New +$12.1K ﹤0.01% 13034
2023
Q1
Sell
-330
Closed -$36.1K 16267
2022
Q4
$36.1K Buy
+330
New +$49.3K ﹤0.01% 12530

Other funds holding CMAX

Citadel Advisors's CMAX Position: Q1 2024 in Review

Citadel Advisors sold out of CareMax, Inc. Class A Common Stock (CMAX) in Q1 2024, closing a stake of 2,824 shares — an estimated $42.2K sold.

Citadel Advisors first reported a position in CMAX in Q3 2021 and held it in 8 quarters. The position peaked at $1.99M in Q2 2022. 42 funds tracked by Wall St. Rank hold CMAX as of Q1 2024.

  • Citadel Advisors reported no remaining CareMax, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Citadel Advisors sold 2,824 CareMax, Inc. Class A Common Stock shares in Q1 2024, an estimated $42.2K.
  • Citadel Advisors first reported a position in CareMax, Inc. Class A Common Stock in Q3 2021 and held it in 8 quarters.
  • Citadel Advisors's CareMax, Inc. Class A Common Stock position peaked at $1.99M in Q2 2022.
  • 42 funds tracked by Wall St. Rank held CareMax, Inc. Class A Common Stock as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.